80 related articles for article (PubMed ID: 2615086)
21. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary complications after bone marrow transplantation].
Giacchino M; Busca A; Miniero R; Defilippi C; Massara FM; Vassallo E; Madon E
Minerva Pediatr; 1993 Apr; 45(4):141-50. PubMed ID: 8355644
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
24. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
Schmeiser T; Heit W
Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
[TBL] [Abstract][Full Text] [Related]
25. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
26. [Infectious complications and infection prevention in patients with acute leukemia].
Teshima H; Kanakura Y; Ishihara K; Soma T; Hirayama F; Kubota Y; Kojima K; Ueda T; Tsubakio T; Nakamura H
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1211-7. PubMed ID: 3863970
[TBL] [Abstract][Full Text] [Related]
27. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
[TBL] [Abstract][Full Text] [Related]
28. [Indication and results of bone marrow transplantation in acute leukemia].
Masaoka T; Inoue T
Gan To Kagaku Ryoho; 1986 May; 13(5):1811-5. PubMed ID: 3518637
[TBL] [Abstract][Full Text] [Related]
29. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
31. [Effects of regimens of total body irradiation on interstitial pneumonitis after bone marrow transplantation].
Sugawara T; Inoue T; Mori T; Iino Y; Masaoka T
Gan No Rinsho; 1988 Mar; 34(3):311-20. PubMed ID: 3282090
[TBL] [Abstract][Full Text] [Related]
32. Interstitial pneumonitis after BMT: 15 years experience in a single institution.
Grañena A; Carreras E; Rozman C; Salgado C; Sierra J; Algara M; Rovira M; Valls A
Bone Marrow Transplant; 1993 Jun; 11(6):453-8. PubMed ID: 8392885
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
de Medeiros CR; Moreira VA; Pasquini R
Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
[TBL] [Abstract][Full Text] [Related]
34. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
35. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation.
Huang X; Guo N; Ren H; Zhang Y; Gao Z; Lu D
Chin Med J (Engl); 2003 May; 116(5):736-41. PubMed ID: 12875692
[TBL] [Abstract][Full Text] [Related]
36. Total body irradiation for allogeneic bone marrow transplantation in acute leukemia: a co-operative study from the TBI Subcommittee in Japan.
Inoue T; Masaoka T; Shibata H
Strahlenther Onkol; 1986 Feb; 162(2):100-4. PubMed ID: 3513354
[TBL] [Abstract][Full Text] [Related]
37. Late-onset interstitial pneumonia following allogeneic bone marrow transplantation.
Wingard JR; Santos GW; Saral R
Transplantation; 1985 Jan; 39(1):21-3. PubMed ID: 2981443
[TBL] [Abstract][Full Text] [Related]
38. The lung as a critical organ in marrow transplantation.
Quabeck K
Bone Marrow Transplant; 1994; 14 Suppl 4():S19-28. PubMed ID: 7728120
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.
von Bueltzingsloewen A; Bordigoni P; Witz F; Bene MC; Schmitt C; Lacour B; Sommelet D
Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller CA; Kanz L
Bone Marrow Transplant; 2000 Apr; 25(7):757-63. PubMed ID: 10745262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
